+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Reporter Gene Assay Market - Global Forecast 2026-2032- Product Image
Reporter Gene Assay Market - Global Forecast 2026-2032- Product Image
Sale

Reporter Gene Assay Market - Global Forecast 2026-2032

  • Report

  • 183 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 6012351
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Reporter Gene Assay Market is projected to reach USD 3.64 Billion in 2026. It is expected to continue growing at a CAGR of 8.32%, reaching USD 5.90 Billion by 2032.

The reporter gene assay market sits at the center of modern cell-based assay development, enabling researchers to quantify gene expression, promoter activity, receptor signaling, pathway modulation, and compound-induced cellular responses. By linking a regulatory sequence or signaling event to a measurable reporter such as luciferase, fluorescent proteins, beta-galactosidase, or secreted alkaline phosphatase, these assays convert complex biology into reproducible readouts for drug discovery, toxicology, immunology, oncology, virology, and synthetic biology.

Demand is supported by well-established use in high-throughput screening, mechanism-of-action studies, biologics characterization, gene regulation research, and safety assessment workflows. Adoption is strongest where laboratories require sensitivity, dynamic range, automation compatibility, and robust statistical performance. As pharmaceutical and biotechnology pipelines increasingly prioritize targeted therapies, immune signaling, viral biology, endocrine pathways, and advanced cell-based models, reporter gene assays remain a validated and scalable tool for translating molecular activity into decision-ready data.

Transformative Shifts in Reporter Gene Assay Adoption

The landscape is shifting from endpoint-only assays toward integrated, automation-ready platforms that combine engineered cell lines, optimized reporter constructs, miniaturized microplate formats, and multiplexed detection. Luciferase-based reporter assays continue to be favored for sensitivity and broad dynamic range, while fluorescent and luminescent reporters are increasingly used in live-cell, kinetic, and multiplex formats where temporal biology is critical.

Another major shift is the move toward more physiologically relevant systems, including stable reporter cell lines, CRISPR-edited models, organoids, co-culture systems, and immune-cell-based assays. These systems are improving translational relevance for oncology, inflammation, infectious disease, metabolic disease, and endocrine disruption research. At the same time, quality expectations are rising, with laboratories prioritizing assay validation, signal-to-background performance, reproducibility, cell line authentication, and compatibility with regulatory-aligned bioassay practices.

Cumulative Impact of Artificial Intelligence on Reporter Gene Assays

Artificial intelligence is changing reporter gene assay workflows by strengthening experimental design, image and signal interpretation, anomaly detection, and high-throughput data analytics. Machine learning models can help identify plate effects, flag outliers, optimize dose-response curve fitting, improve quality control, and support hit selection by integrating reporter readouts with orthogonal data such as transcriptomics, phenotypic imaging, pathway analysis, and compound structure information.

The cumulative impact is operational as well as scientific. AI-enabled laboratory informatics and automation platforms reduce manual review burden, improve assay consistency, and support faster decision-making across screening campaigns. In regulated or quality-controlled environments, AI adoption is most valuable when paired with transparent validation, auditability, data integrity controls, and human scientific review, ensuring that productivity gains do not compromise confidence in reporter gene assay results.

Key Regional Insights: Asia-Pacific, North America, Europe, Latin America, Middle East, and Africa

Asia-Pacific is expanding as a high-growth region for reporter gene assays, supported by strong life science manufacturing, contract research activity, government-backed biotechnology initiatives, and growing investment in cell-based screening across China, India, Japan, South Korea, Australia, and Southeast Asia. Regional laboratories are increasingly using reporter assays in oncology, infectious disease, immunology, vaccine research, and biologics development. North America remains a leading innovation hub because of its concentration of pharmaceutical developers, biotechnology companies, academic medical centers, assay technology providers, and high-throughput screening infrastructure, with the United States and Canada supporting advanced use of automated cell-based assays, luciferase reporter assays, and gene expression analysis.

Europe benefits from mature biomedical research networks, strong regulatory science, and advanced biopharmaceutical development across Germany, the United Kingdom, France, Italy, Spain, and other research-intensive economies. The region’s emphasis on assay validation, reproducibility, and ethical biomedical research supports adoption in drug discovery, toxicology, and advanced therapy development. Latin America is gaining traction through expanding academic research, clinical research activity, and pharmaceutical partnerships, particularly in Brazil and Mexico. The Middle East is building capacity through healthcare diversification, genomics programs, and research infrastructure investment, while Africa shows long-term potential as biomedical research networks, infectious disease programs, public health laboratories, and laboratory modernization initiatives continue to develop.

Key Group Insights: ASEAN, GCC, European Union, BRICS, G7, and NATO

ASEAN is becoming increasingly relevant for reporter gene assay adoption as member economies strengthen biomedical research, biologics manufacturing support, university-linked innovation, and contract research capabilities. Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines are contributing to broader regional demand for cell-based assays through life science infrastructure upgrades and translational research programs. The GCC is investing in healthcare transformation, precision medicine, genomics, and research infrastructure, creating selective opportunities for reporter gene assay technologies in translational research, public health, and academic-industry collaborations.

The European Union offers a harmonized regulatory and research environment that supports assay standardization, cross-border collaboration, quality-focused laboratory practices, and innovation funding for biomedical science. BRICS economies are important for scale, scientific talent, and expanding pharmaceutical development, with China, India, and Brazil playing prominent roles in cost-efficient research ecosystems and Russia and South Africa contributing to regional scientific capacity. G7 countries remain central to advanced assay innovation, regulatory leadership, high-value biopharmaceutical pipelines, and sophisticated high-throughput screening infrastructure, while NATO member markets overlap substantially with major North American and European research hubs that prioritize biosecurity, infectious disease preparedness, vaccine research, and advanced biotechnology capabilities.

Key Country Insights Across Major Reporter Gene Assay Markets

The United States leads in reporter gene assay innovation due to its dense network of biotechnology firms, pharmaceutical R&D centers, contract research organizations, academic laboratories, and technology suppliers. Canada contributes through strong academic biomedical research, translational science, and biologics development, while Mexico supports regional growth through expanding pharmaceutical manufacturing and research services. Brazil is the primary Latin American market, anchored by biomedical institutions, public health research, pharmaceutical production, and a growing life sciences base.

In Europe, the United Kingdom remains influential in genomics, cell biology, immunology, and drug discovery; Germany combines industrial biotechnology strength with advanced laboratory infrastructure; France supports robust public-private biomedical research; Russia has scientific capacity in molecular biology, pharmacology, and virology; and Italy and Spain contribute through pharmaceutical production, academic research, and clinical development networks. In Asia-Pacific, China has rapidly scaled biotechnology, cell-based screening, and biopharmaceutical development capabilities; India offers a large research services and pharmaceutical ecosystem; Japan remains a leader in precision instrumentation, cell biology, and drug discovery science; Australia supports translational biomedical research and clinical research collaboration; and South Korea is advancing through biologics, cell therapy, regenerative medicine, and life science technology investment.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize assay robustness by investing in validated reporter constructs, authenticated cell lines, optimized detection reagents, and standardized operating procedures. Commercial teams should align product portfolios with high-value use cases such as oncology signaling, immune checkpoint biology, nuclear receptor profiling, viral entry and replication studies, gene therapy analytics, toxicity testing, and biologics potency assessment.

Organizations should also expand automation and informatics capabilities to improve throughput, traceability, and reproducibility. Partnerships with contract research organizations, academic centers, and biopharmaceutical developers can accelerate adoption, while region-specific strategies should address local regulatory expectations, budget constraints, technical support requirements, sample logistics, and training needs. AI should be implemented with governance frameworks that preserve data integrity, explainability, validation, and scientific accountability.

Research Methodology

This executive summary is developed using a structured secondary research approach that synthesizes verified industry knowledge from established scientific literature, regulatory guidance, technology documentation, public research programs, peer-reviewed assay validation practices, and life science sector indicators. The methodology emphasizes triangulation across assay technology trends, application demand, regional R&D activity, and end-user adoption patterns.

Insights are assessed through qualitative validation focused on technical relevance, commercial applicability, and consistency with known laboratory practices. The analysis considers reporter types, detection modalities, cell-based assay workflows, pharmaceutical and biotechnology use cases, regional research infrastructure, and the growing role of automation, informatics, and artificial intelligence in assay execution and interpretation. No market sizing, market share, or forecasting assumptions are included.

Conclusion

Reporter gene assays continue to be a foundational technology for measuring cellular responses with precision, scalability, and biological relevance. Their value is reinforced by expanding applications in drug discovery, toxicology, immunology, oncology, infectious disease research, gene therapy development, biologics characterization, and advanced therapeutic research.

Future adoption will be shaped by validated cell models, automation-compatible workflows, AI-supported analytics, and regional expansion of biotechnology infrastructure. Organizations that combine scientific rigor with workflow efficiency, data integrity, and application-specific solutions will be best positioned to address evolving demand in the reporter gene assay market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Reporter Gene Assay Market, by Product Type
7.1. Introduction
7.2. Assay Kits
7.2.1. Luciferase Reporter Systems
7.2.2. Dual-Reporter Kits
7.2.3. Galactosidase Assays
7.2.4. Fluorescent Protein Assays
7.3. Instruments & Hardware
7.3.1. Luminometers
7.3.2. Fluorescence Microscopes/Imaging Systems
7.3.3. Imaging Systems
7.3.4. Plate Readers with Spectral Scanning
7.4. Reporter Cell Lines
7.5. Consumables & Accessories
7.5.1. Microplates (96-well, 384-well)
7.5.2. Transfection Reagents
7.5.3. Cell Culture Media & Supplements
7.5.4. Filtration Plates & Pipette Tips
8. Reporter Gene Assay Market, by Technology
8.1. Introduction
8.2. Enzymatic/Colorimetric Reporters
8.3. Fluorescent Protein Reporters
8.4. Luminescence Assay
8.5. Bioluminescent Reporters
8.6. Advanced Technology & Hybrid Systems
9. Reporter Gene Assay Market, by Therapeutic Area
9.1. Introduction
9.2. Oncology
9.3. Immunology & Inflammation
9.4. Infectious Diseases
9.5. Neurology
9.6. Metabolic Disorders
10. Reporter Gene Assay Market, by Screening Throughput
10.1. Introduction
10.2. Low-Throughput Screening
10.3. Medium-Throughput Screening
10.4. High-Throughput Screening (HTS)
11. Reporter Gene Assay Market, by Application
11.1. Introduction
11.2. Gene Expression Studies
11.3. Signal Transduction Pathway Analysis
11.4. Drug Discovery & Development
11.5. Promoter Activity Analysis
11.6. Cell Line Development & Validation
11.7. Toxicity Testing
12. Reporter Gene Assay Market, by End User
12.1. Introduction
12.2. Pharmaceutical & Biotechnology Companies
12.3. Academic & Research Institutes
12.4. Contract Research Organizations (CROs)
12.5. Clinical Research Laboratories
13. Reporter Gene Assay Market, by Region
13.1. Asia-Pacific
13.2. North America
13.3. Europe
13.4. Latin America
13.5. Africa
13.6. Middle East
14. Reporter Gene Assay Market, by Group
14.1. NATO
14.2. G7
14.3. BRICS
14.4. European Union
14.5. ASEAN
14.6. GCC
15. Reporter Gene Assay Market, by Country
15.1. United States
15.2. China
15.3. Canada
15.4. Japan
15.5. India
15.6. Germany
15.7. Brazil
15.8. Mexico
15.9. United Kingdom
15.10. France
15.11. Australia
15.12. Italy
15.13. South Korea
15.14. Russia
15.15. Spain
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. FPNV Positioning Matrix, 2025
16.3. Market Concentration Analysis, 2025
16.3.1. Concentration Ratio (CR)
16.3.2. Herfindahl Hirschman Index (HHI)
16.4. Recent Developments & Impact Analysis, 2025
16.5. Product Portfolio Analysis, 2025
16.6. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Thermo Fisher Scientific Inc.
17.2. Merck KGaA
17.3. Promega Corporation
17.4. Revvity, Inc.
17.5. Danaher Corporation
17.6. QIAGEN N.V.
17.7. Sartorius AG
17.8. Agilent Technologies, Inc.
17.9. Takara Bio Inc.
17.10. Berthold Technologies GmbH & Co. KG
17.11. InvivoGen SAS
17.12. Eurofins Scientific SE
17.13. Lonza Group AG
17.14. Becton, Dickinson and Company
17.15. F. Hoffmann-La Roche AG
17.16. AAT Bioquest, Inc.
17.17. Active Motif, Inc.
17.18. Bio-Rad Laboratories, Inc.
17.19. Biotium, Inc.
17.20. BMG LABTECH GmbH
17.21. Bps Bioscience Inc.
17.22. Cayman Chemical Company
17.23. Cell Signaling Technology, Inc.
17.24. Charles River Laboratories International, Inc.
17.25. Enzo Biochem, Inc.
17.26. GeneCopoeia, Inc.
17.27. GenScript Biotech Corporation
17.28. Indigo Biosciences, Inc.
17.29. NanoTemper Technologies. Inc.
17.30. New England Biolabs, Inc.
17.31. OriGene Technologies, Inc.
17.32. OZ BIOSCIENCES USA, INC.
17.33. PromoCell GmbH
17.34. Reaction Biology Corp.
17.35. SGS SA
17.36. SYSTEM BIOSCIENCES LLC by CellBio Scientific, LLC
17.37. Toyobo Co., Ltd.
17.38. WuXi AppTec Co., Ltd.
List of Figures
FIGURE 1. GLOBAL REPORTER GENE ASSAY MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL REPORTER GENE ASSAY MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL REPORTER GENE ASSAY MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL REPORTER GENE ASSAY MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL REPORTER GENE ASSAY MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL REPORTER GENE ASSAY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL REPORTER GENE ASSAY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL REPORTER GENE ASSAY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 9. GLOBAL REPORTER GENE ASSAY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL REPORTER GENE ASSAY MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2032 (%)
FIGURE 11. GLOBAL REPORTER GENE ASSAY MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL REPORTER GENE ASSAY MARKET SIZE, BY SCREENING THROUGHPUT, 2025 VS 2032 (%)
FIGURE 13. GLOBAL REPORTER GENE ASSAY MARKET SIZE, BY SCREENING THROUGHPUT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL REPORTER GENE ASSAY MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL REPORTER GENE ASSAY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL REPORTER GENE ASSAY MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 17. GLOBAL REPORTER GENE ASSAY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL REPORTER GENE ASSAY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL REPORTER GENE ASSAY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL REPORTER GENE ASSAY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 21. GLOBAL REPORTER GENE ASSAY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL REPORTER GENE ASSAY MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 23. GLOBAL REPORTER GENE ASSAY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL REPORTER GENE ASSAY MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 25. GLOBAL REPORTER GENE ASSAY MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL REPORTER GENE ASSAY MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL REPORTER GENE ASSAY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL REPORTER GENE ASSAY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL ASSAY KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL ASSAY KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL ASSAY KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL LUCIFERASE REPORTER SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL LUCIFERASE REPORTER SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL LUCIFERASE REPORTER SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL DUAL-REPORTER KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL DUAL-REPORTER KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL DUAL-REPORTER KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL GALACTOSIDASE ASSAYS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL GALACTOSIDASE ASSAYS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL GALACTOSIDASE ASSAYS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL FLUORESCENT PROTEIN ASSAYS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL FLUORESCENT PROTEIN ASSAYS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL FLUORESCENT PROTEIN ASSAYS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL INSTRUMENTS & HARDWARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL INSTRUMENTS & HARDWARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL INSTRUMENTS & HARDWARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL LUMINOMETERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL LUMINOMETERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL LUMINOMETERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL FLUORESCENCE MICROSCOPES/IMAGING SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL FLUORESCENCE MICROSCOPES/IMAGING SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL FLUORESCENCE MICROSCOPES/IMAGING SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL IMAGING SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL IMAGING SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL IMAGING SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL PLATE READERS WITH SPECTRAL SCANNING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL PLATE READERS WITH SPECTRAL SCANNING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL PLATE READERS WITH SPECTRAL SCANNING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL REPORTER CELL LINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL REPORTER CELL LINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL REPORTER CELL LINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL CONSUMABLES & ACCESSORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL CONSUMABLES & ACCESSORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL CONSUMABLES & ACCESSORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL MICROPLATES (96-WELL, 384-WELL) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL MICROPLATES (96-WELL, 384-WELL) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL MICROPLATES (96-WELL, 384-WELL) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL TRANSFECTION REAGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL TRANSFECTION REAGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL TRANSFECTION REAGENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL CELL CULTURE MEDIA & SUPPLEMENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL CELL CULTURE MEDIA & SUPPLEMENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL CELL CULTURE MEDIA & SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL FILTRATION PLATES & PIPETTE TIPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL FILTRATION PLATES & PIPETTE TIPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL FILTRATION PLATES & PIPETTE TIPS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL REPORTER GENE ASSAY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL ENZYMATIC/COLORIMETRIC REPORTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL ENZYMATIC/COLORIMETRIC REPORTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL ENZYMATIC/COLORIMETRIC REPORTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL FLUORESCENT PROTEIN REPORTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL FLUORESCENT PROTEIN REPORTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL FLUORESCENT PROTEIN REPORTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL LUMINESCENCE ASSAY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL LUMINESCENCE ASSAY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL LUMINESCENCE ASSAY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL BIOLUMINESCENT REPORTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL BIOLUMINESCENT REPORTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL BIOLUMINESCENT REPORTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL ADVANCED TECHNOLOGY & HYBRID SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL ADVANCED TECHNOLOGY & HYBRID SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL ADVANCED TECHNOLOGY & HYBRID SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL REPORTER GENE ASSAY MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL IMMUNOLOGY & INFLAMMATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL IMMUNOLOGY & INFLAMMATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL IMMUNOLOGY & INFLAMMATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL NEUROLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL NEUROLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL NEUROLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL REPORTER GENE ASSAY MARKET SIZE, BY SCREENING THROUGHPUT, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL LOW-THROUGHPUT SCREENING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL LOW-THROUGHPUT SCREENING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL LOW-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL MEDIUM-THROUGHPUT SCREENING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL MEDIUM-THROUGHPUT SCREENING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL MEDIUM-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL HIGH-THROUGHPUT SCREENING (HTS) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL HIGH-THROUGHPUT SCREENING (HTS) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL HIGH-THROUGHPUT SCREENING (HTS) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL REPORTER GENE ASSAY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL GENE EXPRESSION STUDIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL GENE EXPRESSION STUDIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL GENE EXPRESSION STUDIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL SIGNAL TRANSDUCTION PATHWAY ANALYSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL SIGNAL TRANSDUCTION PATHWAY ANALYSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL SIGNAL TRANSDUCTION PATHWAY ANALYSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL DRUG DISCOVERY & DEVELOPMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL DRUG DISCOVERY & DEVELOPMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL DRUG DISCOVERY & DEVELOPMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL PROMOTER ACTIVITY ANALYSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL PROMOTER ACTIVITY ANALYSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL PROMOTER ACTIVITY ANALYSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL CELL LINE DEVELOPMENT & VALIDATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL CELL LINE DEVELOPMENT & VALIDATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL CELL LINE DEVELOPMENT & VALIDATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL TOXICITY TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL TOXICITY TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL TOXICITY TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL REPORTER GENE ASSAY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL CONTRACT RESEARCH ORGANIZATIONS (CROS) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL CONTRACT RESEARCH ORGANIZATIONS (CROS) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL CONTRACT RESEARCH ORGANIZATIONS (CROS) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL CLINICAL RESEARCH LABORATORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL CLINICAL RESEARCH LABORATORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 125. GLOBAL CLINICAL RESEARCH LABORATORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL REPORTER GENE ASSAY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 127. ASIA-PACIFIC REPORTER GENE ASSAY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 128. ASIA-PACIFIC REPORTER GENE ASSAY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 129. ASIA-PACIFIC REPORTER GENE ASSAY MARKET SIZE, BY ASSAY KITS, 2017-2032 (USD MILLION)
TABLE 130. ASIA-PACIFIC REPORTER GENE ASSAY MARKET SIZE, BY INSTRUMENTS & HARDWARE, 2017-2032 (USD MILLION)
TABLE 131. ASIA-PACIFIC REPORTER GENE ASSAY MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 132. ASIA-PACIFIC REPORTER GENE ASSAY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 133. ASIA-PACIFIC REPORTER GENE ASSAY MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 134. ASIA-PACIFIC REPORTER GENE ASSAY MARKET SIZE, BY SCREENING THROUGHPUT, 2017-2032 (USD MILLION)
TABLE 135. ASIA-PACIFIC REPORTER GENE ASSAY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 136. ASIA-PACIFIC REPORTER GENE ASSAY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 137. NORTH AMERICA REPORTER GENE ASSAY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 138. NORTH AMERICA REPORTER GENE ASSAY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 139. NORTH AMERICA REPORTER GENE ASSAY MARKET SIZE, BY ASSAY KITS, 2017-2032 (USD MILLION)
TABLE 140. NORTH AMERICA REPORTER GENE ASSAY MARKET SIZE, BY INSTRUMENTS & HARDWARE, 2017-2032 (USD MILLION)
TABLE 141. NORTH AMERICA REPORTER GENE ASSAY MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 142. NORTH AMERICA REPORTER GENE ASSAY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 143. NORTH AMERICA REPORTER GENE ASSAY MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 144. NORTH AMERICA REPORTER GENE ASSAY MARKET SIZE, BY SCREENING THROUGHPUT, 2017-2032 (USD MILLION)
TABLE 145. NORTH AMERICA REPORTER GENE ASSAY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 146. NORTH AMERICA REPORTER GENE ASSAY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 147. EUROPE REPORTER GENE ASSAY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 148. EUROPE REPORTER GENE ASSAY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 149. EUROPE REPORTER GENE ASSAY MARKET SIZE, BY ASSAY KITS, 2017-2032 (USD MILLION)
TABLE 150. EUROPE REPORTER GENE ASSAY MARKET SIZE, BY INSTRUMENTS & HARDWARE, 2017-2032 (USD MILLION)
TABLE 151. EUROPE REPORTER GENE ASSAY MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 152. EUROPE REPORTER GENE ASSAY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 153. EUROPE REPORTER GENE ASSAY MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 154. EUROPE REPORTER GENE ASSAY MARKET SIZE, BY SCREENING THROUGHPUT, 2017-2032 (USD MILLION)
TABLE 155. EUROPE REPORTER GENE ASSAY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 156. EUROPE REPORTER GENE ASSAY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 157. LATIN AMERICA REPORTER GENE ASSAY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 158. LATIN AMERICA REPORTER GENE ASSAY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 159. LATIN AMERICA REPORTER GENE ASSAY MARKET SIZE, BY ASSAY KITS, 2017-2032 (USD MILLION)
TABLE 160. LATIN AMERICA REPORTER GENE ASSAY MARKET SIZE, BY INSTRUMENTS & HARDWARE, 2017-2032 (USD MILLION)
TABLE 161. LATIN AMERICA REPORTER GENE ASSAY MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 162. LATIN AMERICA REPORTER GENE ASSAY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 163. LATIN AMERICA REPORTER GENE ASSAY MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 164. LATIN AMERICA REPORTER GENE ASSAY MARKET SIZE, BY SCREENING THROUGHPUT, 2017-2032 (USD MILLION)
TABLE 165. LATIN AMERICA REPORTER GENE ASSAY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 166. LATIN AMERICA REPORTER GENE ASSAY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 167. AFRICA REPORTER GENE ASSAY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 168. AFRICA REPORTER GENE ASSAY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 169. AFRICA REPORTER GENE ASSAY MARKET SIZE, BY ASSAY KITS, 2017-2032 (USD MILLION)
TABLE 170. AFRICA REPORTER GENE ASSAY MARKET SIZE, BY INSTRUMENTS & HARDWARE, 2017-2032 (USD MILLION)
TABLE 171. AFRICA REPORTER GENE ASSAY MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 172. AFRICA REPORTER GENE ASSAY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 173. AFRICA REPORTER GENE ASSAY MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 174. AFRICA REPORTER GENE ASSAY MARKET SIZE, BY SCREENING THROUGHPUT, 2017-2032 (USD MILLION)
TABLE 175. AFRICA REPORTER GENE ASSAY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 176. AFRICA REPORTER GENE ASSAY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 177. MIDDLE EAST REPORTER GENE ASSAY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 178. MIDDLE EAST REPORTER GENE ASSAY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 179. MIDDLE EAST REPORTER GENE ASSAY MARKET SIZE, BY ASSAY KITS, 2017-2032 (USD MILLION)
TABLE 180. MIDDLE EAST REPORTER GENE ASSAY MARKET SIZE, BY INSTRUMENTS & HARDWARE, 2017-2032 (USD MILLION)
TABLE 181. MIDDLE EAST REPORTER GENE ASSAY MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 182. MIDDLE EAST REPORTER GENE ASSAY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 183. MIDDLE EAST REPORTER GENE ASSAY MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 184. MIDDLE EAST REPORTER GENE ASSAY MARKET SIZE, BY SCREENING THROUGHPUT, 2017-2032 (USD MILLION)
TABLE 185. MIDDLE EAST REPORTER GENE ASSAY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 186. MIDDLE EAST REPORTER GENE ASSAY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 187. GLOBAL REPORTER GENE ASSAY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 188. NATO REPORTER GENE ASSAY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 189. NATO REPORTER GENE ASSAY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 190. NATO REPORTER GENE ASSAY MARKET SIZE, BY ASSAY KITS, 2017-2032 (USD MILLION)
TABLE 191. NATO REPORTER GENE ASSAY MARKET SIZE, BY INSTRUMENTS & HARDWARE, 2017-2032 (USD MILLION)
TABLE 192. NATO REPORTER GENE ASSAY MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 193. NATO REPORTER GENE ASSAY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 194. NATO REPORTER GENE ASSAY MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 195. NATO REPORTER GENE ASSAY MARKET SIZE, BY SCREENING THROUGHPUT, 2017-2032 (USD MILLION)
TABLE 196. NATO REPORTER GENE ASSAY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 197. NATO REPORTER GENE ASSAY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 198. G7 REPORTER GENE ASSAY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 199. G7 REPORTER GENE ASSAY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 200. G7 REPORTER GENE ASSAY MARKET SIZE, BY ASSAY KITS, 2017-2032 (USD MILLION)
TABLE 201. G7 REPORTER GENE ASSAY MARKET SIZE, BY INSTRUMENTS & HARDWARE, 2017-2032 (USD MILLION)
TABLE 202. G7 REPORTER GENE ASSAY MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 203. G7 REPORTER GENE ASSAY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 204. G7 REPORTER GENE ASSAY MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 205. G7 REPORTER GENE ASSAY MARKET SIZE, BY SCREENING THROUGHPUT, 2017-2032 (USD MILLION)
TABLE 206. G7 REPORTER GENE ASSAY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 207. G7 REPORTER GENE ASSAY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 208. BRICS REPORTER GENE ASSAY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 209. BRICS REPORTER GENE ASSAY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 210. BRICS REPORTER GENE ASSAY MARKET SIZE, BY ASSAY KITS, 2017-2032 (USD MILLION)
TABLE 211. BRICS REPORTER GENE ASSAY MARKET SIZE, BY INSTRUMENTS & HARDWARE, 2017-2032 (USD MILLION)
TABLE 212. BRICS REPORTER GENE ASSAY MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 213. BRICS REPORTER GENE ASSAY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 214. BRICS REPORTER GENE ASSAY MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 215. BRICS REPORTER GENE ASSAY MARKET SIZE, BY SCREENING THROUGHPUT, 2017-2032 (USD MILLION)
TABLE 216. BRICS REPORTER GENE ASSAY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 217. BRICS REPORTER GENE ASSAY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 218. EUROPEAN UNION REPORTER GENE ASSAY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 219. EUROPEAN UNION REPORTER GENE ASSAY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 220. EUROPEAN UNION REPORTER GENE ASSAY MARKET SIZE, BY ASSAY KITS, 2017-2032 (USD MILLION)
TABLE 221. EUROPEAN UNION REPORTER GENE ASSAY MARKET SIZE, BY INSTRUMENTS & HARDWARE, 2017-2032 (USD MILLION)
TABLE 222. EUROPEAN UNION REPORTER GENE ASSAY MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 223. EUROPEAN UNION REPORTER GENE ASSAY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 224. EUROPEAN UNION REPORTER GENE ASSAY MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 225. EUROPEAN UNION REPORTER GENE ASSAY MARKET SIZE, BY SCREENING THROUGHPUT, 2017-2032 (USD MILLION)
TABLE 226. EUROPEAN UNION REPORTER GENE ASSAY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 227. EUROPEAN UNION REPORTER GENE ASSAY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 228. ASEAN REPORTER GENE ASSAY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 229. ASEAN REPORTER GENE ASSAY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 230. ASEAN REPORTER GENE ASSAY MARKET SIZE, BY ASSAY KITS, 2017-2032 (USD MILLION)
TABLE 231. ASEAN REPORTER GENE ASSAY MARKET SIZE, BY INSTRUMENTS & HARDWARE, 2017-2032 (USD MILLION)
TABLE 232. ASEAN REPORTER GENE ASSAY MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 233. ASEAN REPORTER GENE ASSAY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 234. ASEAN REPORTER GENE ASSAY MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 235. ASEAN REPORTER GENE ASSAY MARKET SIZE, BY SCREENING THROUGHPUT, 2017-2032 (USD MILLION)
TABLE 236. ASEAN REPORTER GENE ASSAY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 237. ASEAN REPORTER GENE ASSAY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 238. GCC REPORTER GENE ASSAY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 239. GCC REPORTER GENE ASSAY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 240. GCC REPORTER GENE ASSAY MARKET SIZE, BY ASSAY KITS, 2017-2032 (USD MILLION)
TABLE 241. GCC REPORTER GENE ASSAY MARKET SIZE, BY INSTRUMENTS & HARDWARE, 2017-2032 (USD MILLION)
TABLE 242. GCC REPORTER GENE ASSAY MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 243. GCC REPORTER GENE ASSAY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 244. GCC REPORTER GENE ASSAY MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 245. GCC REPORTER GENE ASSAY MARKET SIZE, BY SCREENING THROUGHPUT, 2017-2032 (USD MILLION)
TABLE 246. GCC REPORTER GENE ASSAY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 247. GCC REPORTER GENE ASSAY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 248. GLOBAL REPORTER GENE ASSAY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 249. UNITED STATES REPORTER GENE ASSAY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 250. UNITED STATES REPORTER GENE ASSAY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 251. UNITED STATES REPORTER GENE ASSAY MARKET SIZE, BY ASSAY KITS, 2017-2032 (USD MILLION)
TABLE 252. UNITED STATES REPORTER GENE ASSAY MARKET SIZE, BY INSTRUMENTS & HARDWARE, 2017-2032 (USD MILLION)
TABLE 253. UNITED STATES REPORTER GENE ASSAY MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 254. UNITED STATES REPORTER GENE ASSAY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 255. UNITED STATES REPORTER GENE ASSAY MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 256. UNITED STATES REPORTER GENE ASSAY MARKET SIZE, BY SCREENING THROUGHPUT, 2017-2032 (USD MILLION)
TABLE 257. UNITED STATES REPORTER GENE ASSAY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 258. UNITED STATES REPORTER GENE ASSAY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 259. CHINA REPORTER GENE ASSAY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 260. CHINA REPORTER GENE ASSAY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 261. CHINA REPORTER GENE ASSAY MARKET SIZE, BY ASSAY KITS, 2017-2032 (USD MILLION)
TABLE 262. CHINA REPORTER GENE ASSAY MARKET SIZE, BY INSTRUMENTS & HARDWARE, 2017-2032 (USD MILLION)
TABLE 263. CHINA REPORTER GENE ASSAY MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 264. CHINA REPORTER GENE ASSAY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 265. CHINA REPORTER GENE ASSAY MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 266. CHINA REPORTER GENE ASSAY MARKET SIZE, BY SCREENING THROUGHPUT, 2017-2032 (USD MILLION)
TABLE 267. CHINA REPORTER GENE ASSAY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 268. CHINA REPORTER GENE ASSAY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 269. CANADA REPORTER GENE ASSAY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 270. CANADA REPORTER GENE ASSAY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 271. CANADA REPORTER GENE ASSAY MARKET SIZE, BY ASSAY KITS, 2017-2032 (USD MILLION)
TABLE 272. CANADA REPORTER GENE ASSAY MARKET SIZE, BY INSTRUMENTS & HARDWARE, 2017-2032 (USD MILLION)
TABLE 273. CANADA REPORTER GENE ASSAY MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 274. CANADA REPORTER GENE ASSAY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 275. CANADA REPORTER GENE ASSAY MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 276. CANADA REPORTER GENE ASSAY MARKET SIZE, BY SCREENING THROUGHPUT, 2017-2032 (USD MILLION)
TABLE 277. CANADA REPORTER GENE ASSAY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 278. CANADA REPORTER GENE ASSAY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 279. JAPAN REPORTER GENE ASSAY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 280. JAPAN REPORTER GENE ASSAY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 281. JAPAN REPORTER GENE ASSAY MARKET SIZE, BY ASSAY KITS, 2017-2032 (USD MILLION)
TABLE 282. JAPAN REPORTER GENE ASSAY MARKET SIZE, BY INSTRUMENTS & HARDWARE, 2017-2032 (USD MILLION)
TABLE 283. JAPAN REPORTER GENE ASSAY MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 284. JAPAN REPORTER GENE ASSAY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 285. JAPAN REPORTER GENE ASSAY MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 286. JAPAN REPORTER GENE ASSAY MARKET SIZE, BY SCREENING THROUGHPUT, 2017-2032 (USD MILLION)
TABLE 287. JAPAN REPORTER GENE ASSAY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 288. JAPAN REPORTER GENE ASSAY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 289. INDIA REPORTER GENE ASSAY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 290. INDIA REPORTER GENE ASSAY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 291. INDIA REPORTER GENE ASSAY MARKET SIZE, BY ASSAY KITS, 2017-2032 (USD MILLION)
TABLE 292. INDIA REPORTER GENE ASSAY MARKET SIZE, BY INSTRUMENTS & HARDWARE, 2017-2032 (USD MILLION)
TABLE 293. INDIA REPORTER GENE ASSAY MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 294. INDIA REPORTER GENE ASSAY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 295. INDIA REPORTER GENE ASSAY MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 296. INDIA REPORTER GENE ASSAY MARKET SIZE, BY SCREENING THROUGHPUT, 2017-2032 (USD MILLION)
TABLE 297. INDIA REPORTER GENE ASSAY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 298. INDIA REPORTER GENE ASSAY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 299. GERMANY REPORTER GENE ASSAY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 300. GERMANY REPORTER GENE ASSAY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 301. GERMANY REPORTER GENE ASSAY MARKET SIZE, BY ASSAY KITS, 2017-2032 (USD MILLION)
TABLE 302. GERMANY REPORTER GENE ASSAY MARKET SIZE, BY INSTRUMENTS & HARDWARE, 2017-2032 (USD MILLION)
TABLE 303. GERMANY REPORTER GENE ASSAY MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 304. GERMANY REPORTER GENE ASSAY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 305. GERMANY REPORTER GENE ASSAY MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 306. GERMANY REPORTER GENE ASSAY MARKET SIZE, BY SCREENING THROUGHPUT, 2017-2032 (USD MILLION)
TABLE 307. GERMANY REPORTER GENE ASSAY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 308. GERMANY REPORTER GENE ASSAY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 309. BRAZIL REPORTER GENE ASSAY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 310. BRAZIL REPORTER GENE ASSAY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 311. BRAZIL REPORTER GENE ASSAY MARKET SIZE, BY ASSAY KITS, 2017-2032 (USD MILLION)
TABLE 312. BRAZIL REPORTER GENE ASSAY MARKET SIZE, BY INSTRUMENTS & HARDWARE, 2017-2032 (USD MILLION)
TABLE 313. BRAZIL REPORTER GENE ASSAY MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 314. BRAZIL REPORTER GENE ASSAY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 315. BRAZIL REPORTER GENE ASSAY MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 316. BRAZIL REPORTER GENE ASSAY MARKET SIZE, BY SCREENING THROUGHPUT, 2017-2032 (USD MILLION)
TABLE 317. BRAZIL REPORTER GENE ASSAY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 318. BRAZIL REPORTER GENE ASSAY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 319. MEXICO REPORTER GENE ASSAY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 320. MEXICO REPORTER GENE ASSAY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 321. MEXICO REPORTER GENE ASSAY MARKET SIZE, BY ASSAY KITS, 2017-2032 (USD MILLION)
TABLE 322. MEXICO REPORTER GENE ASSAY MARKET SIZE, BY INSTRUMENTS & HARDWARE, 2017-2032 (USD MILLION)
TABLE 323. MEXICO REPORTER GENE ASSAY MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 324. MEXICO REPORTER GENE ASSAY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 325. MEXICO REPORTER GENE ASSAY MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 326. MEXICO REPORTER GENE ASSAY MARKET SIZE, BY SCREENING THROUGHPUT, 2017-2032 (USD MILLION)
TABLE 327. MEXICO REPORTER GENE ASSAY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 328. MEXICO REPORTER GENE ASSAY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 329. UNITED KINGDOM REPORTER GENE ASSAY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 330. UNITED KINGDOM REPORTER GENE ASSAY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 331. UNITED KINGDOM REPORTER GENE ASSAY MARKET SIZE, BY ASSAY KITS, 2017-2032 (USD MILLION)
TABLE 332. UNITED KINGDOM REPORTER GENE ASSAY MARKET SIZE, BY INSTRUMENTS & HARDWARE, 2017-2032 (USD MILLION)
TABLE 333. UNITED KINGDOM REPORTER GENE ASSAY MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 334. UNITED KINGDOM REPORTER GENE ASSAY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 335. UNITED KINGDOM REPORTER GENE ASSAY MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 336. UNITED KINGDOM REPORTER GENE ASSAY MARKET SIZE, BY SCREENING THROUGHPUT, 2017-2032 (USD MILLION)
TABLE 337. UNITED KINGDOM REPORTER GENE ASSAY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 338. UNITED KINGDOM REPORTER GENE ASSAY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 339. FRANCE REPORTER GENE ASSAY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 340. FRANCE REPORTER GENE ASSAY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 341. FRANCE REPORTER GENE ASSAY MARKET SIZE, BY ASSAY KITS, 2017-2032 (USD MILLION)
TABLE 342. FRANCE REPORTER GENE ASSAY MARKET SIZE, BY INSTRUMENTS & HARDWARE, 2017-2032 (USD MILLION)
TABLE 343. FRANCE REPORTER GENE ASSAY MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 344. FRANCE REPORTER GENE ASSAY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 345. FRANCE REPORTER GENE ASSAY MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 346. FRANCE REPORTER GENE ASSAY MARKET SIZE, BY SCREENING THROUGHPUT, 2017-2032 (USD MILLION)
TABLE 347. FRANCE REPORTER GENE ASSAY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 348. FRANCE REPORTER GENE ASSAY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 349. AUSTRALIA REPORTER GENE ASSAY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 350. AUSTRALIA REPORTER GENE ASSAY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 351. AUSTRALIA REP

Companies Mentioned

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Promega Corporation
  • Revvity, Inc.
  • Danaher Corporation
  • QIAGEN N.V.
  • Sartorius AG
  • Agilent Technologies, Inc.
  • Takara Bio Inc.
  • Berthold Technologies GmbH & Co. KG
  • InvivoGen SAS
  • Eurofins Scientific SE
  • Lonza Group AG
  • Becton, Dickinson and Company
  • F. Hoffmann-La Roche AG
  • AAT Bioquest, Inc.
  • Active Motif, Inc.
  • Bio-Rad Laboratories, Inc.
  • Biotium, Inc.
  • BMG LABTECH GmbH
  • Bps Bioscience Inc.
  • Cayman Chemical Company
  • Cell Signaling Technology, Inc.
  • Charles River Laboratories International, Inc.
  • Enzo Biochem, Inc.
  • GeneCopoeia, Inc.
  • GenScript Biotech Corporation
  • Indigo Biosciences, Inc.
  • NanoTemper Technologies. Inc.
  • New England Biolabs, Inc.
  • OriGene Technologies, Inc.
  • OZ BIOSCIENCES USA, INC.
  • PromoCell GmbH
  • Reaction Biology Corp.
  • SGS SA
  • SYSTEM BIOSCIENCES LLC by CellBio Scientific, LLC
  • Toyobo Co., Ltd.
  • WuXi AppTec Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages183
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 3.64 Billion
Forecasted Market Value ( USD ) by 2032 $ 5.9 Billion
Compound Annual Growth Rate8.3%
Regions CoveredGlobal
No. of Companies Mentioned38

Related Topics

Related Reports

Reporter Gene Assays - Global Strategic Business Report - Product Image

Reporter Gene Assays - Global Strategic Business Report

  • Report
  • 170 Pages
  • Global
From
Reporter Gene Assay Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Reporter Gene Assay Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 185 Pages
  • Global
From
Reporter Gene Assay - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Reporter Gene Assay - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 110 Pages
  • Global
From
Reporter Gene Assay Market Report 2026 - Product Image

Reporter Gene Assay Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Cell-based Assay Market - Global Forecast 2026-2032 - Product Image

Cell-based Assay Market - Global Forecast 2026-2032

  • Report
  • 198 Pages
  • Global
From

About the Reporter Gene Assay Market

The Reporter Gene Assay market is a segment of the biotechnology industry that focuses on the development and use of reporter genes. Reporter genes are genes that are used to detect and measure the expression of other genes. They are used in a variety of applications, including drug discovery, gene therapy, and diagnostics. Reporter gene assays are used to measure the activity of a gene, such as its expression level, in a sample. They are also used to detect the presence of a gene in a sample. The Reporter Gene Assay market is driven by the increasing demand for gene-based diagnostics and therapeutics. The market is also driven by the increasing demand for personalized medicine and the development of new technologies for gene expression analysis. Some of the major companies in the Reporter Gene Assay market include Thermo Fisher Scientific, Promega Corporation, Merck KGaA, Bio-Rad Laboratories, and Agilent Technologies. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.